Prevalence and characteristics of antidepressant prescribing in adults with comorbid depression and type 2 diabetes mellitus: A systematic review and meta-analysis
Health Sciences Review · 2021
DOI: 10.1016/j.hsr.2021.100002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Health Sciences Review, 2021. Verfasst von Annie Jeffery und 6 weiteren Autor:innen. Beteiligte Einrichtung: Epidemiology and Applied Clinical Research Department, Division of Psychiatry, University College London (UCL), London, United Kingdom. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Wellcome Trust, NIHR.
Themen: Diabetes mellitus, Depression
Abstract (Originalsprache)
BACKGROUND: Treatment guidelines do not provide specific recommendations for antidepressant prescribing in people with type 2 diabetes mellitus (T2DM). It is important to understand the prevalence of antidepressant prescribing and associated patient characteristics, to recognise safety issues or inequalities related to treatment access. METHODS AND RESULTS: Seven databases were searched using terms related to depression, T2DM and antidepressant medication. From 14,389 reports retrieved, 9 met inclusion criteria. The prevalence of antidepressant prescribing varied considerably between studies from 18% to 87%. Where meta-analyses were possible, the pooled odds ratio for receiving an antidepressant were 1.52 (95% confidence intervals (CIs) 1.28 - 1.82) in women compared to men, 0.53 (95% CIs 0.23-1.20%) in Black and Ethnic Minorities compared to White ethnicity and 1.29 (95% CIs 0.92-1.80) in insulin users compared to individuals with non-insulin controlled T2DM. CONCLUSIONS: Antidepressant prescribing is more common in women with T2DM compared to men, however, the difference is less than in the general population. Insulin users, representing individuals with more advanced T2DM, were as likely to be prescribed antidepressants as those who did not use insulin. There is a gap in the literature concerning which antidepressant agents are being prescribed, and alongside which concurrent medications and comorbidities.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Epidemiology and Applied Clinical Research Department, Division of Psychiatry, University College London (UCL), London, United Kingdom.
- Department of Primary Care & Population Health, Institute of Epidemiology & Health, University College London (UCL), London, United Kingdom.
- Research Department of Practice and Policy, School of Pharmacy, University College London (UCL), London, United Kingdom.
- Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong.
Förderung
- Wellcome Trust
- NIHR
Zitieren
APA
Jeffery, A., Maconick, L., Francis, E., Walters, K., Wong, I. C. K., Osborn, D., & Hayes, J. F. (2021). Prevalence and characteristics of antidepressant prescribing in adults with comorbid depression and type 2 diabetes mellitus: A systematic review and meta-analysis. Health Sciences Review. https://doi.org/10.1016/j.hsr.2021.100002
Vancouver
Jeffery A, Maconick L, Francis E, Walters K, Wong ICK, Osborn D, et al. Prevalence and characteristics of antidepressant prescribing in adults with comorbid depression and type 2 diabetes mellitus: A systematic review and meta-analysis. Health Sciences Review. 2021. doi:10.1016/j.hsr.2021.100002
BibTeX
@article{Jeffery2021,
author = {Jeffery, Annie and Maconick, Lucy and Francis, Emma and Walters, Kate and Wong, Ian C K and Osborn, David and Hayes, Joseph F},
title = {Prevalence and characteristics of antidepressant prescribing in adults with comorbid depression and type 2 diabetes mellitus: A systematic review and meta-analysis},
journal = {Health Sciences Review},
year = {2021},
doi = {10.1016/j.hsr.2021.100002}
}
EUVIMED